Related Articles
Antisense Bcl-2 and HER-2 oligonucleotide treatment of breast cancer cells enhances their sensitivity to anticancer drugs
Rationale for sequential tamoxifen and anticancer drugs in adjuvant setting for patients with node- and receptor-positive breast cancer
Activation and the interaction of proapoptotic genes in modulating sensitivity to anticancer drugs in gastric cancer cells.
Death receptor-dependent and -independent pathways in anticancer drug-induced apoptosis of breast cancer cells
Cellular sensitivity determinants to docetaxel in human gastrointestinal cancers